15,000 Shares in UnitedHealth Group Incorporated $UNH Purchased by Rovida Advisors Inc.

Rovida Advisors Inc. acquired a new stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 15,000 shares of the healthcare conglomerate's stock, valued at approximately $4,677,000. UnitedHealth Group comprises 0.7% of Rovida Advisors Inc.'s investment portfolio, making the stock its 22nd largest position.

• Snowflake Stock Is on Fire—It’s Still Not Too Late to Buy

Other hedge funds and other institutional investors also recently modified their holdings of the company. LFA Lugano Financial Advisors SA purchased a new position in shares of UnitedHealth Group in the second quarter valued at $25,000. Bayforest Capital Ltd grew its position in UnitedHealth Group by 685.7% in the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock worth $29,000 after acquiring an additional 48 shares in the last quarter. Islay Capital Management LLC purchased a new position in shares of UnitedHealth Group during the 2nd quarter valued at about $31,000. Clal Insurance Enterprises Holdings Ltd boosted its stake in shares of UnitedHealth Group by 416.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock valued at $32,000 after purchasing an additional 50 shares in the last quarter. Finally, Glass Jacobson Investment Advisors llc grew its stake in shares of UnitedHealth Group by 80.9% during the second quarter. Glass Jacobson Investment Advisors llc now owns 123 shares of the healthcare conglomerate's stock valued at $38,000 after buying an additional 55 shares during the last quarter. Institutional investors own 87.86% of the company's stock.

UnitedHealth Group Price Performance

Shares of UNH opened at $309.19 on Thursday. The company has a market capitalization of $280.08 billion, a P/E ratio of 16.14, a price-to-earnings-growth ratio of 2.28 and a beta of 0.47. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $622.83. The company has a quick ratio of 0.85, a current ratio of 0.82 and a debt-to-equity ratio of 0.71. The firm has a 50 day moving average of $346.20 and a 200 day moving average of $317.57.

• UnitedHealth Group’s Recovery in Full Swing: Buy While It's Down

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, topping the consensus estimate of $2.87 by $0.05. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The firm had revenue of $113.16 billion during the quarter, compared to analysts' expectations of $113.19 billion. During the same quarter in the previous year, the business earned $7.15 earnings per share. The company's revenue was up 12.2% on a year-over-year basis. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 16th. Stockholders of record on Monday, December 8th will be paid a $2.21 dividend. The ex-dividend date is Monday, December 8th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.9%. UnitedHealth Group's payout ratio is currently 46.14%.

Analyst Ratings Changes

• Big Banks Are Setting the Tone as Earnings Season Kicks Off

Several brokerages have weighed in on UNH. Jefferies Financial Group increased their price target on shares of UnitedHealth Group from $317.00 to $409.00 and gave the company a "buy" rating in a research report on Friday, October 17th. The Goldman Sachs Group initiated coverage on shares of UnitedHealth Group in a research note on Tuesday, October 14th. They set a "buy" rating and a $406.00 target price on the stock. Cantor Fitzgerald restated an "overweight" rating and issued a $440.00 price objective on shares of UnitedHealth Group in a report on Tuesday, August 26th. Weiss Ratings raised UnitedHealth Group from a "sell (d+)" rating to a "hold (c-)" rating in a research report on Friday, October 24th. Finally, Truist Financial upped their price target on UnitedHealth Group from $310.00 to $365.00 and gave the stock a "buy" rating in a research note on Tuesday, September 9th. Eighteen investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $397.12.

View Our Latest Report on UNH

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Stories

• Five stocks we like better than UnitedHealth Group
• How to Invest in Blue Chip Stocks
• Is Tesla Setting Up for a Year-End Rebound—or a Collapse?
• Stock Market Upgrades: What Are They?
• Applied Materials: Up 40% in 2025 With Room to Run Long-Term
• Why Special Dividends Can be a Delightful Surprise for Income Investors
• onsemi Places a $6 Billion Bet on Its Own Stock

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here